Poor-quality medicines threaten families, countries and global health progress everywhere, and yet they are rarely prioritized – or even discussed –by political leaders, health advocates, researchers or journalists. Those people who have committed to work on safe, quality medicines often lack platforms to coordinate their advocacy for maximum impact.
This is where we come in. A campaign on the right to safe, quality medicines can:
Generate a sense of urgency by raising awareness of the scope and impact of the problem
Put people and their experiences first to illustrate that poor-quality medicines cannot be confined to technical, isolated conversations; they are a fundamental breach of patient trust with life-or-death consequences
Inspire collective action and unify a diverse and broad coalition of partners
Since its launch in 2018, more than 250 civil society organizations, philanthropic foundations, government entities and private partners from across 15 countries have joined Meds We Can Trust.
The good news is that we have proven solutions to protect medicine quality.
To ensure everyone has access to safe, quality medicines, four decisive actions are needed at local, regional and global levels:
Donors prioritize investments in regulatory systems and quality assurance is incorporated into procurement, manufacturing and distribution practices.
Countries establish strong regulatory systems that prevent poor-quality medicines from moving through the supply chain, and find and remove them when they do.
Health workers are stewards of quality who rely on trusted sources and follow up with patients and relevant regulatory authority when they suspect treatment failure related to poor-quality medicines.
Patients and consumers know what to look for, report suspicious products and demand quality in their medicines.
Watch Video Recap of Campaign Announcement
On 23 May 2018, on the sidelines of the 71st World Health Assembly in Geneva, USP and partners announced a new campaign on the right to safe, quality medicines at an event entitled "Medicines We Can Trust: A Call to Safeguard Quality." Watch the recap here.
Campaign Steering Committee
We can't afford to wait any longer. This is a problem that puts millions of lives at risk, costs economies billions, accelerates antimicrobial resistance and undermines trust in health systems. The time to act is now.
Here’s what some of our partners and champions have to say:
A pharmacist reviews her dispensation records at a health facility in Lusaka, Zambia. © 2014 Gareth Bentley/SCMS, Courtesy of Photoshare